Anika Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $93.2M | $365.6M | $95.8M |
| FY2021 | $60.5M | $347.5M | $94.4M |
| FY2022 | $63.6M | $349.1M | $86.3M |
| FY2023 | $58.4M | $270.6M | $68.7M |
| FY2024 | $48.8M | $202.7M | $55.6M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $93.2M | $365.6M | $95.8M |
| FY2021 | $60.5M | $347.5M | $94.4M |
| FY2022 | $63.6M | $349.1M | $86.3M |
| FY2023 | $58.4M | $270.6M | $68.7M |
| FY2024 | $48.8M | $202.7M | $55.6M |